Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin C Collins

Showing results (31-40 of 95) with videos related to

Pageof 10
Sort By:
International Journal of Cancer|February 15, 2018
Aneustat (OMN54) has aerobic glycolysis-inhibitory activity and also immunomodulatory activity as indicated by a first-generation PDX prostate cancer modelSifeng Qu, Hui Xue, Xin Dong, et al.
Oncotarget|July 30, 2014
The BIRC6 gene as a novel target for therapy of prostate cancer: dual targeting of inhibitors of apoptosisSze Ue Iris Luk, Hui Xue, Hongwei Cheng, et al.
Genome Research|August 4, 2017
HIT'nDRIVE: patient-specific multidriver gene prioritization for precision oncologyRaunak Shrestha, Ermin Hodzic, Thomas Sauerwald, et al.
Plos One|July 19, 2014
Systematic identification and characterization of RNA editing in prostate tumorsFan Mo, Alexander W Wyatt, Yue Sun, et al.
British Journal of Cancer|January 31, 2018
Treatment with docetaxel in combination with Aneustat leads to potent inhibition of metastasis in a patient-derived xenograft model of advanced prostate cancerSifeng Qu, Xinpei Ci, Hui Xue, et al.
Cold Spring Harbor Molecular Case Studies|September 3, 2017
A germline FANCA alteration that is associated with increased sensitivity to DNA damaging agentsDavid C Wilkes, Verena Sailer, Hui Xue, et al.
The Prostate|August 28, 2019
Metagenomic analysis reveals a rich bacterial content in high-risk prostate tumors from African menYe Feng, Weerachai Jaratlerdsiri, Sean M Patrick, et al.
Cells|June 10, 2020
Conditionally Reprogrammed Cells from Patient-Derived Xenograft to Model Neuroendocrine Prostate Cancer DevelopmentXinpei Ci, Jun Hao, Xin Dong, et al.
Bioinformatics (Oxford, England)|December 22, 2017
Computational identification of micro-structural variations and their proteogenomic consequences in cancerYen-Yi Lin, Alexander Gawronski, Faraz Hach, et al.
Clinical Epigenetics|April 11, 2015
Polycomb-mediated silencing in neuroendocrine prostate cancerPier-Luc Clermont, Dong Lin, Francesco Crea, et al.
Pageof 10

Showing results (31-40 of 95) with videos related to

Sort By:
Pageof 10
International Journal of Cancer|February 15, 2018
Aneustat (OMN54) has aerobic glycolysis-inhibitory activity and also immunomodulatory activity as indicated by a first-generation PDX prostate cancer modelSifeng Qu, Hui Xue, Xin Dong, et al.
Oncotarget|July 30, 2014
The BIRC6 gene as a novel target for therapy of prostate cancer: dual targeting of inhibitors of apoptosisSze Ue Iris Luk, Hui Xue, Hongwei Cheng, et al.
Genome Research|August 4, 2017
HIT'nDRIVE: patient-specific multidriver gene prioritization for precision oncologyRaunak Shrestha, Ermin Hodzic, Thomas Sauerwald, et al.
Plos One|July 19, 2014
Systematic identification and characterization of RNA editing in prostate tumorsFan Mo, Alexander W Wyatt, Yue Sun, et al.
British Journal of Cancer|January 31, 2018
Treatment with docetaxel in combination with Aneustat leads to potent inhibition of metastasis in a patient-derived xenograft model of advanced prostate cancerSifeng Qu, Xinpei Ci, Hui Xue, et al.
Cold Spring Harbor Molecular Case Studies|September 3, 2017
A germline FANCA alteration that is associated with increased sensitivity to DNA damaging agentsDavid C Wilkes, Verena Sailer, Hui Xue, et al.
The Prostate|August 28, 2019
Metagenomic analysis reveals a rich bacterial content in high-risk prostate tumors from African menYe Feng, Weerachai Jaratlerdsiri, Sean M Patrick, et al.
Cells|June 10, 2020
Conditionally Reprogrammed Cells from Patient-Derived Xenograft to Model Neuroendocrine Prostate Cancer DevelopmentXinpei Ci, Jun Hao, Xin Dong, et al.
Bioinformatics (Oxford, England)|December 22, 2017
Computational identification of micro-structural variations and their proteogenomic consequences in cancerYen-Yi Lin, Alexander Gawronski, Faraz Hach, et al.
Clinical Epigenetics|April 11, 2015
Polycomb-mediated silencing in neuroendocrine prostate cancerPier-Luc Clermont, Dong Lin, Francesco Crea, et al.
Pageof 10